Low Omicron Efficacy behind Delay of Pfizer Covid Vaccine for Kids under 5- WSJ

Reuters2022-02-18

Feb 18 (Reuters) - U.S. health regulators delayed the review of Pfizer Inc's COVID-19 vaccine for children under 5 years of age because its two-dose regimen did not work well against the Omicron ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Success88
    2022-02-19
    Success88
    🙏🙏🙏 Please like 
  • Jloong
    2022-02-19
    Jloong
    a
  • MFME
    2022-02-19
    MFME
    Can we overcome it once and for all.
  • ty91
    2022-02-19
    ty91
    Ok
  • xoomix
    2022-02-19
    xoomix
    Like
  • PearlynCSY
    2022-02-19
    PearlynCSY
    Musk and safe distance should continue to prevent the alarmingly high infection and fatality rates. The number of death cases already hit a million in the US
Leave a comment
27